We have temporarily paused our Prompt Prostate Genetic Score™ (PGS) test and we are not accepting orders at this time. We expect the product will remain paused until at least December 31, 2022. Contact clientservices@invitae.com if you have questions.

In the Press

Read about all the latest developments with Prompt PGS in the featured articles and press releases below.

AUA DAILY NEWS

Risk-adapted decision-making replaces one-size-fits-all approach to prostate cancer

VIEW FULL ARTICLE

STRATIFY GENOMICS, NOW PROMPT GENOMICS

Stratify Genomics Announces Telemedicine Initiative During Virus Crisis

VIEW FULL ARTICLE

Urology Times

An End to the Decline in Prostate Cancer Mortality

VIEW FULL ARTICLE

STRATIFY GENOMICS, NOW PROMPT GENOMICS

Stratify Genomics Announces Hispanic Validation of Prompt PGS Test for Lifetime Risk of Prostate Cancer

VIEW FULL ARTICLE

For press inquiries, please contact Gina Anderson at gina.anderson@invitae.com.

×